Investor

News & Events

Financial Reports

SEC Filings Annual Report & Proxy Additional Financial Information

Stock Information

Stock Quote Stock Chart Key Ratios Historical Price Lookup Investment Calculator Analyst Coverage Interactive Analyst Center

Corporate Governance

Overview Board of Directors Board Committees

Contacts & Alerts

Email Alerts Contact IR Request Printed Materials

Investors

"One of the Core Values we live by at Danaher is We Compete for Shareholders, and we believe we are uniquely positioned to deliver meaningful, long-term shareholder value for many years to come."

RAINER M. BLAIR
President and CEO

NYSEDHR

Investor Relations

Danaher’s proven business system drives performance. We are proud to be a Fortune 200 company, and our stock has outperformed the S&P 500 index by more than 2,000% over the past 25 years.

Quarterly Results

Q2 2024 Results

Earnings release

Presentation

Webcast

View all quarterly results

Latest Event purple and pink abstract

Danaher Diagnostics Investor & Analyst Event

09.04.24 - 09.05.24

6:00pm - 1:00pm EDT

Press Releases

Jul 23, 2024

Danaher Reports Second Quarter 2024 Results

Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended June 28, 2024. All results in this release reflect only continuing operations unless otherwise noted....

Jul 17, 2024

Danaher Announces Two New Centers of Innovation in Diagnostics to Transform Precision Medicine Development

DH Diagnostics LLC Centers aim to accelerate drug development by speeding and streamlining development and commercialization of companion diagnostics. Clinical Laboratory Improvement Amendments...

Jul 16, 2024

Danaher Releases 2024 Sustainability Report

Danaher Corporation (NYSE: DHR) ("Danaher" or the "Company"), the global life sciences and diagnostics innovator, today published its 2024 Sustainability Report which conveys the depth and scope...

View all news

Company Overview